Archer Daniels Midland Co.   Report issue

For profit Phase 2
Founded: Minneapolis MN United States (1902)
Status: No NME R&D (1902)

Organization Overview

First Clinical Trial
2007
NCT01314586
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

ADM Korea Inc | Probiotics International Ltd. | The Archer-Daniels-Midland Company

Active Ingredients

Drugs in Phase 2 Trials (1)

pm012 (1 trial)

Drugs in Other Trials (3)

maltodextrin (1 trial)

secoisolariciresinol (1 trial)

soybean (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4